Hypothalamic-pituitary-adrenal hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways
Notes: Acute tolerance (a reduction in response for a given dose) develops rapidly (less than 1 hour), but not at the same rate for different physiologic effects (skin temperature, heart rate, subjective effects) Withdrawal symptoms such as cigarette craving can be reduced in most individuals by plasma nicotine levels lower than those from smoking Withdrawal from nicotine in addicted individuals can be characterized by craving, nervousness, restlessness, irritability, mood lability, anxiety, drowsiness, sleep disturbances, impaired concentration, increased appetite, minor somatic complaints (headache, myalgia, constipation, fatigue), and weight gain References: Belkoniene M et al (2019): Near fatal intoxication by nicotine and propylene glycol injection: a case report of an e-liquid poisoning
2014 Jan;9(1):106-17
2 Materials and Methods 2.1 Clinical Data The model was developed using data from six clinical pharmacology trials that assessed: the effects of water volume and post-dose fasting (NCT01572753) [15], tablet degradation assessed by scintigraphy (NCT01619345) [16], renal impairment (NCT02014259) [17], hepatic impairment (NCT02016911) [18], drugdrug interaction with omeprazole (NCT02249871) [19] and food intake (NCT02172313) [20] on the PK of oral semaglutide (Table 1)
International Agency for Research on Cancer (IARC), 156-165, 2015
